TP53 and neoplasm: Herein, somatic mutation analysis revealed that the prevalence of TP53 and TTN mutations in the high-risk group was high, which is consistent with the findings reported in existing studies and associates these mutations with aggressive tumor phenotypes and poor prognosis in LUAD.